| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.8 |